"/> Novus Biologicals™ Peptide bloquant d’anticorps Lg… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps Lgi3

Réf. : BL-RE-049682Réf. fabricant : 18289955 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
203190
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-76383. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 12 amino acids near the center of human LGI3.

Points forts

Source

Synthetic

(Accession #: AAQ88483) The Lgi3 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-049682
Réf. fabricant18289955
Gene ID (Entrez)203190
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-76383. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneLeucine-rich glioma-inactivated protein 3, leucine-rich repeat LGI family member 3, leucine-rich repeat LGI family, member 3, LGI1-like protein 4, LGIL4
Symbole de gène(s)LGI3
Type de produitLgi3
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne12 amino acids near the center of human LGI3
Une question, une configuration particulière ?
Contactez-nous pour un devis.